drugset / Trial / NCT00959465
A/H1N1 Immunogenicity and Safety in Adults
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of the study is to obtain immunogenicity and safety data at different dose levels of an investigational H1N1 pandemic influenza vaccine in healthy adults 18 years of age and older.
Timeline
- Start
- 2009-08
- Primary completion
- 2009-11
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | H1N1 pandemic influenza vaccine | Vaccine | — | — |